menu

Exploring the Mechanisms of Resistance to Targeted Therapies in CLL & MCL

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Exploring the Mechanisms of Resistance to Targeted Therapies in CLL & MCL

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    Dr. Charles Turck is joined by Dr. Andrew Lipsky to examine the mechanisms contributing to acquired resistance in CLL and MCL targeted therapies and outline strategies to prevent this resistance.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    Dr. Charles Turck is joined by Dr. Andrew Lipsky to examine the mechanisms contributing to acquired resistance in CLL and MCL targeted therapies and outline strategies to prevent this resistance.

Facebook Comments

Schedule15 Aug 2022
Webpack App